Ware Olivia C
- SEC CIK
- 0001663771
No open-market purchases or sales filed in the past year.
Current role at each company
- CTNM Contineum Therapeutics, Inc.Directoras of Jun 26, 2026
- ACLX Arcellx, Inc.Directoras of Apr 28, 2026
- RVNC Revance Therapeutics, Inc.Directoras of Feb 6, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ware Olivia C as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ACLX Arcellx, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 18, 2024 (view filing) | Apr 16 | 2 days | Ware Olivia CDirector | SSale | −9.40K | $55.55 | −$522.2K | −100.0%0 after | 2 lots10b5-1 |
| Mar 18, 2024 (view filing) | Mar 15 | 3 days | Ware Olivia CDirector | SSale | −9.00K | $70.40 | −$633.6K | −100.0%0 after | 3 lots10b5-1 |